Moxifloxacin Versus Ceftriaxone in the Treatment of Primary Pyogenic Liver Abscess

PHASE4CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2011

Conditions
Liver Abscess
Interventions
DRUG

Moxifloxacin (Avelox)

moxifloxacin 400 mg IV qd for 14 days, followed by moxifloxacin 400 mg po qd for another 1 week

DRUG

ceftriaxone

ceftriaxone 2 gm IV q 12 h for 14 days, followed by cephalexin 1 gm PO q 6 h for 1 week

Trial Locations (1)

813

Kaohsiung Veterans General Hospital, Kaohsiung City

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Kaohsiung Veterans General Hospital.

OTHER